Literature DB >> 10898329

Rapid onset of hematotoxic effects after interferon alpha in hepatitis C.

H Dormann, S Krebs, U Muth-Selbach, K Brune, D Schuppan, E G Hahn, H T Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10898329     DOI： 10.1016/s0168-8278(00)80113-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.

Authors:  A H Lashin; Y A Shaheen; M A Metwally; H M El-Feky; M F Hegab; S M Abbas
Journal:  Indian J Gastroenterol       Date:  2013-05-29

2.  HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.

Authors:  Yalena Amador-Cañizares; Gillian Martínez-Donato; Liz Alvarez-Lajonchere; Claudia Vasallo; Mariacarla Dausá; Daylen Aguilar-Noriega; Carmen Valenzuela; Ivette Raíces; Jean Dubuisson; Czeslaw Wychowski; Zurina Cinza-Estévez; Marlén Castellanos; Magdalys Núñez; Anny Armas; Yaimé González; Ismariley Revé; Ivis Guerra; Angel Pérez Aguiar; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.

Authors:  M Schmid; A Kreil; W Jessner; M Homoncik; C Datz; A Gangl; P Ferenci; M Peck-Radosavljevic
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Does a rapid decline in the hematological and biochemical parameters induced by interferon and ribavirin combination therapy for the hepatitis C virus predict a sustained viral response?

Authors:  C Turbide; C Soulellis; M Deschênes; N Hilzenrat
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.